Dinner S, Liedtke M. Antibody-based therapies in patients with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2018 ; 2018 : 9.
Raponi S, De Propris MS, Intoppa S, et al. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia : analysis of 552 cases. Leuk Lymphoma 2011 ; 52 : 1098.
Poe JC, Fujimoto Y, Hasegawa M, et al. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol 2004 ; 5 : 1078.
Kantarjian H, Ravandi F, Short NJ, et al. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia : a single-arm, phase 2 study. Lancet Oncol 2018 ; 19 : 240.